Auris Medical Provides Business Update
Net cash inflow of $13.4 million from recent registered direct offering and warrant exercises AM-301 program progressing towards clinical and
Read moreNasdaq:EARS
Auris Medical Holding to Present at the 13th Annual LD Micro Main Event Conference
Hamilton, Bermuda, December 7, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that
Read moreAuris Medical Holding Ltd. Prices $8,000,000 Common Shares Offering Priced At-the-Market
Hamilton, Bermuda, December 2, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS) (“Auris” or the “Company”), a clinical-stage company dedicated
Read moreAuris Medical Holding Ltd. Prices $8,000,000 Common Shares Offering Priced At-the-Market
Hamilton, Bermuda, December 2, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS) (“Auris” or the “Company”), a clinical-stage company dedicated
Read moreAuris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV-2 Infection
Up to 99.4% reduction of viral titer in human epithelial cell culture (p<0.001) Results suggest potential for AM-301 nasal spray
Read moreAuris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV-2 Infection
Up to 99.4% reduction of viral titer in human epithelial cell culture (p<0.001) Results suggest potential for AM-301 nasal spray
Read moreAuris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV-2 Infection
Up to 99.4% reduction of viral titer in human epithelial cell culture (p<0.001) Results suggest potential for AM-301 nasal spray
Read moreAuris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV-2 Infection
Up to 99.4% reduction of viral titer in human epithelial cell culture (p<0.001) Results suggest potential for AM-301 nasal spray
Read moreAuris Medical Launches Website for AM-301-focused Subsidiary, Altamira Medica
Hamilton, Bermuda, November 20, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that
Read moreAuris Medical Launches Website for AM-301-focused Subsidiary, Altamira Medica
Hamilton, Bermuda, November 20, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that
Read more